{
    "2020-06-05": [
        [
            {
                "time": "",
                "original_text": "药明康德(02359)董事及高级管理人员拟减持不超20.69万股A股股份 拟减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "董事",
                        "高级管理人员",
                        "减持",
                        "A股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "减持！药明康德：部分董监高人员拟合计减持不超过20.69万股股份 拟减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "董监高",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259.SH)：部分董事、高管拟减持不超20.6898万股 拟减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "董事",
                        "高管",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：董事、高级管理人员拟减持不超0.0090%股份 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "董事",
                        "高级管理人员",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业6月投资策略：后疫情时代 把握恢复性子行业和医药“新基建”增量赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "后疫情",
                        "恢复性子行业",
                        "新基建"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[民生医药|周报]：不确定外部环境下，中国市场红利持续",
                "features": {
                    "keywords": [
                        "民生医药",
                        "周报",
                        "不确定外部环境",
                        "中国市场红利"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[民生医药|外包] 不确定外部环境下，中国市场红利持续",
                "features": {
                    "keywords": [
                        "民生医药",
                        "外包",
                        "不确定外部环境",
                        "中国市场红利"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股融资融券日报：两融余额增加19.61亿元（6月4日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股上市公司高管薪酬中股权激励占比将提高",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司",
                        "高管薪酬",
                        "股权激励",
                        "提高"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[中航医药】行业周报 | 疫情反复，短期关注产业链投资机会",
                "features": {
                    "keywords": [
                        "中航医药",
                        "行业周报",
                        "疫情反复",
                        "产业链",
                        "投资机会"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}